These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 31678366)
21. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model. Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324 [TBL] [Abstract][Full Text] [Related]
22. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis. Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879 [TBL] [Abstract][Full Text] [Related]
23. Effects of tumor necrosis factor-like ligand 1A (TL1A) on imiquimod-induced psoriasiform skin inflammation in mice. Li L; Fu L; Zhou P; Lu Y; Zhang L; Wang W; Nie J; Zhang D; Liu Y; Wu B; Chen T Arch Dermatol Res; 2020 Sep; 312(7):481-490. PubMed ID: 31953572 [TBL] [Abstract][Full Text] [Related]
24. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells. Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852 [TBL] [Abstract][Full Text] [Related]
25. The Skin-Liver Axis Modulates the Psoriasiform Phenotype and Involves Leucine-Rich α-2 Glycoprotein. Nakajima H; Nakajima K; Takaishi M; Ohko K; Serada S; Fujimoto M; Naka T; Sano S J Immunol; 2021 Apr; 206(7):1469-1477. PubMed ID: 33648938 [TBL] [Abstract][Full Text] [Related]
27. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway. Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468 [TBL] [Abstract][Full Text] [Related]
28. Eosinophils Accelerate Pathogenesis of Psoriasis by Supporting an Inflammatory Milieu that Promotes Neutrophil Infiltration. Kim HJ; Roh JY; Jung Y J Invest Dermatol; 2018 Oct; 138(10):2185-2194. PubMed ID: 29580867 [TBL] [Abstract][Full Text] [Related]
29. IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells. Wang Y; Mao Y; Zhang J; Shi G; Cheng L; Lin Y; Li Y; Zhang X; Zhang Y; Chen X; Deng J; Su X; Dai L; Yang Y; Zhang S; Yu D; Wei Y; Deng H J Cell Mol Med; 2018 Feb; 22(2):1014-1025. PubMed ID: 29193791 [TBL] [Abstract][Full Text] [Related]
30. IFN-κ Is a Rheostat for Development of Psoriasiform Inflammation. Gharaee-Kermani M; Estadt SN; Tsoi LC; Wolf-Fortune SJ; Liu J; Xing X; Theros J; Reed TJ; Lowe L; Gruszka D; Ward NL; Gudjonsson JE; Kahlenberg JM J Invest Dermatol; 2022 Jan; 142(1):155-165.e3. PubMed ID: 34364883 [TBL] [Abstract][Full Text] [Related]
31. Role of keratinocytes and immune cells in the anti-inflammatory effects of Tripterygium wilfordii Hook. f. in a murine model of psoriasis. Ru Y; Li H; Zhang R; Luo Y; Song J; Kuai L; Xing M; Hong S; Sun X; Ding X; Lu Y; Liu L; Na C; Zhou Y; Li B; Li X Phytomedicine; 2020 Oct; 77():153299. PubMed ID: 32823074 [TBL] [Abstract][Full Text] [Related]
32. Resident and monocyte-derived Langerhans cells are required for imiquimod-induced psoriasis-like dermatitis model. Lee M; Kim SH; Kim TG; Park J; Lee JW; Lee MG J Dermatol Sci; 2018 Jul; 91(1):52-59. PubMed ID: 29655588 [TBL] [Abstract][Full Text] [Related]
33. The vitamin D Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055 [TBL] [Abstract][Full Text] [Related]
34. Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms. Sunkari S; Thatikonda S; Pooladanda V; Challa VS; Godugu C Int Immunopharmacol; 2019 Jun; 71():301-312. PubMed ID: 30933843 [TBL] [Abstract][Full Text] [Related]
35. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway. Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569 [TBL] [Abstract][Full Text] [Related]
36. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells. Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823 [TBL] [Abstract][Full Text] [Related]
37. Dimeric translationally controlled tumor protein-binding peptide 2 attenuates imiquimod-induced psoriatic inflammation through induction of regulatory T cells. Cho H; Je JH; Kang J; Jeong MG; Song J; Jeon Y; Lee K; Hwang ES Biomed Pharmacother; 2022 Aug; 152():113245. PubMed ID: 35689858 [TBL] [Abstract][Full Text] [Related]
38. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages. Morimura S; Oka T; Sugaya M; Sato S J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687 [TBL] [Abstract][Full Text] [Related]
39. Anti-psoriatic effect of myeloid-derived suppressor cells on imiquimod-induced skin inflammation in mice. Kim CH; Yoo JK; Jeon SH; Lim CY; Lee JH; Koo DB; Park MY Scand J Immunol; 2019 Mar; 89(3):e12742. PubMed ID: 30548969 [TBL] [Abstract][Full Text] [Related]
40. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production. Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]